.
'indian ip and liabilities law barrier to pharma r&d investment'
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted.
.